topotecan has been researched along with Brain Stem Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arola, M; Clausen, N; Harila-Saari, A; Holm, S; Kivivuori, SM; Lähteenmäki, P; Lannering, B; Lönnqvist, T; Porkholm, M; Riikonen, P; Saarinen-Pihkala, UM; Schomerus, E; Sehested, A; Thomassen, H; Thorarinsdottir, HK; Valanne, L; Wojcik, D | 1 |
Kivivuori, SM; Lönnqvist, T; Riikonen, P; Saarinen-Pihkala, UM; Valanne, L | 1 |
Allen, JC; Belasco, JB; Fisher, PG; Janss, AJ; Minturn, JE; Patti, R; Phillips, PC | 1 |
Anderson, RC; Bruce, JN; Canoll, P; Feldstein, NA; Garvin, J; Kennedy, B; Needle, M; Yanes, CL | 1 |
Ater, J; Geyer, JR; Krailo, MD; Mehta, MP; Needle, MN; Sanghavi, SN | 1 |
Bernier-Chastagner, V; Bracard, S; Chastagner, P; Doz, F; Gentet, JC; Grill, J; Kalifa, C; Laithier, V; Lejars, O; Luporsi, E; Margueritte, G; Marie-Cardine, A; Mechinaud, F; Millot, F | 1 |
3 trial(s) available for topotecan and Brain Stem Neoplasms
Article | Year |
---|---|
A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
Topics: Brain Neoplasms; Brain Stem Neoplasms; Child; Disease-Free Survival; Ependymoma; Female; Glioma; Humans; Male; Neuroectodermal Tumors, Primitive; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome | 2011 |
A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
Topics: Adolescent; Brain Stem Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Glioma; Humans; Infant; Male; Radiation-Sensitizing Agents; Survival Rate; Topotecan | 2003 |
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
Topics: Adolescent; Age Factors; Brain Stem Neoplasms; Child; Child, Preschool; Disease-Free Survival; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Risk Assessment; Survival Analysis; Time Factors; Topotecan; Treatment Outcome | 2005 |
3 other study(ies) available for topotecan and Brain Stem Neoplasms
Article | Year |
---|---|
Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Case-Control Studies; Celecoxib; Chemoradiotherapy; Chemotherapy, Adjuvant; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Glioma; Humans; Infant; Male; Neoplasm Grading; Prognosis; Pyrazoles; Quality of Life; Remission Induction; Sulfonamides; Survival Rate; Thalidomide; Topotecan | 2014 |
Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Celecoxib; Child; Child, Preschool; Disease Progression; Etoposide; Glioma; Humans; Pilot Projects; Pyrazoles; Quality of Life; Radiation-Sensitizing Agents; Sulfonamides; Survival Analysis; Thalidomide; Topotecan; Treatment Outcome | 2011 |
Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
Topics: Antineoplastic Agents; Biopsy; Brain; Brain Stem Neoplasms; Child, Preschool; Combined Modality Therapy; Convection; Drug Delivery Systems; Fatal Outcome; Female; Gait Disorders, Neurologic; Glioma; Humans; Image Processing, Computer-Assisted; Karnofsky Performance Status; Magnetic Resonance Imaging; Nervous System Diseases; Radiography; Topotecan; Treatment Outcome | 2013 |